FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3026970913> ?p ?o ?g. }

• W3026970913 endingPage "867" @default.
• W3026970913 startingPage "860" @default.
• W3026970913 abstract "The aim of the present study was to determine the analgesic effects of ropivacaine combined with different doses of dexmedetomidine for ultrasound‑guided transversus abdominis plane (TAP) block immediately following laparotomy in patients with gynecologic malignancies. A further aim was to determine the appropriate clinical dose of dexmedetomidine as an adjuvant for ropivacaine. Patients with gynecologic malignancies scheduled for laparotomy were randomly assigned to group R (TAP block with 0.3% ropivacaine), group RD1 (TAP block with ropivacaine and 0.5 µg/kg dexmedetomidine), group RD2 (TAP block with ropivacaine and 1 µg/kg dexmedetomidine) and group RD3 (TAP block with ropivacaine and 2 µg/kg dexmedetomidine). TAP blocks were performed post‑operatively. The four groups all received patient‑controlled intravenous analgesia (PCIA) after the operation. The numerical rating scale (NRS) as well as the Ramsay sedation scale (RSS) scores, the first request time for PCIA bolus, oxycodone hydrochloride consumption, the plasma concentration of ropivacaine, the incidence of post‑operative complications and adverse events, and patient satisfaction were recorded. Post‑operative NRS scores at rest exhibited significant differences between the R group and all the RD groups at 24 h after surgery (P<0.05). Compared with the other groups, the NRS score in the RD3 group was decreased (P<0.05). The RSS scores were higher in all of the RD groups compared with those in the R group at 2 h (P<0.05) and were highest in the RD3 group compared with those in all other groups at 4 h (P<0.05). The first request time for PCIA was significantly longer in the RD3 group compared with that in the RD2, RD1 and R groups (510.47±102.67, 595.47±100.11, 682.43±104.46 and 776.42±143.91 min, respectively; P<0.05). Cumulative opioid consumption based on the number of PCIA bolus requested at 24 and 48 h post‑operatively indicated that the total number of PCIA boluses was significantly lower in the RD groups compared with those in the R group at 24 and 48 h (P<0.05). The ropivacaine concentration did not differ among the four groups. There was no significant difference between groups with respect to post‑operative nausea and vomiting, bradycardia and hypotension; however, all RD groups had a higher patient satisfaction than group R (P<0.05). Compared with that in the other groups, the duration of post‑anesthesia care unit stay in group RD3 was relatively longer due to excessive sedation (P<0.05). In conclusion, TAP blockade using 0.5‑2 µg/kg dexmedetomidine combined with 0.3% ropivacaine is a safe and effective treatment for analgesia in laparotomy procedures for gynecologic malignancies. The study was registered in the Chinese Clinical Trial Registry (CHICTR; www.chictr.org.cn) on January 15th, 2019 (registration no. ChiCTR1900020995)." @default.
• W3026970913 created "2020-05-29" @default.
• W3026970913 creator A5008633488 @default.
• W3026970913 creator A5053089392 @default.
• W3026970913 creator A5078992709 @default.
• W3026970913 creator A5084306160 @default.
• W3026970913 date "2020-05-25" @default.
• W3026970913 modified "2023-09-24" @default.
• W3026970913 title "Comparing post‑operative analgesic effects of varying doses of dexmedetomidine as an adjuvant to ropivacaine for ultrasound‑guided dual transversus abdominis plane block following laparotomy for gynecologic malignancies" @default.
• W3026970913 cites W1975352023 @default.
• W3026970913 cites W1981868030 @default.
• W3026970913 cites W1982321451 @default.
• W3026970913 cites W2042928662 @default.
• W3026970913 cites W2051039788 @default.
• W3026970913 cites W2061414979 @default.
• W3026970913 cites W2109691581 @default.
• W3026970913 cites W2140697956 @default.
• W3026970913 cites W2151140115 @default.
• W3026970913 cites W2322306676 @default.
• W3026970913 cites W2518063716 @default.
• W3026970913 cites W2605115935 @default.
• W3026970913 cites W2616453556 @default.
• W3026970913 cites W2767102612 @default.
• W3026970913 cites W2782894689 @default.
• W3026970913 cites W2799605889 @default.
• W3026970913 cites W2891180062 @default.
• W3026970913 cites W2894937599 @default.
• W3026970913 cites W2897283925 @default.
• W3026970913 cites W2898811719 @default.
• W3026970913 cites W2921398642 @default.
• W3026970913 cites W2946731254 @default.
• W3026970913 cites W4465288 @default.
• W3026970913 cites W2414384010 @default.
• W3026970913 doi "https://doi.org/10.3892/etm.2020.8787" @default.
• W3026970913 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7388559" @default.
• W3026970913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32765653" @default.
• W3026970913 hasPublicationYear "2020" @default.
• W3026970913 type Work @default.
• W3026970913 sameAs 3026970913 @default.
• W3026970913 citedByCount "4" @default.
• W3026970913 countsByYear W30269709132021 @default.
• W3026970913 countsByYear W30269709132022 @default.
• W3026970913 countsByYear W30269709132023 @default.
• W3026970913 crossrefType "journal-article" @default.
• W3026970913 hasAuthorship W3026970913A5008633488 @default.
• W3026970913 hasAuthorship W3026970913A5053089392 @default.
• W3026970913 hasAuthorship W3026970913A5078992709 @default.
• W3026970913 hasAuthorship W3026970913A5084306160 @default.
• W3026970913 hasBestOaLocation W30269709131 @default.
• W3026970913 hasConcept C126322002 @default.
• W3026970913 hasConcept C141071460 @default.
• W3026970913 hasConcept C170493617 @default.
• W3026970913 hasConcept C2776029756 @default.
• W3026970913 hasConcept C2776814716 @default.
• W3026970913 hasConcept C2780269707 @default.
• W3026970913 hasConcept C2780778865 @default.
• W3026970913 hasConcept C2780820201 @default.
• W3026970913 hasConcept C2781063702 @default.
• W3026970913 hasConcept C2781302539 @default.
• W3026970913 hasConcept C42219234 @default.
• W3026970913 hasConcept C71924100 @default.
• W3026970913 hasConceptScore W3026970913C126322002 @default.
• W3026970913 hasConceptScore W3026970913C141071460 @default.
• W3026970913 hasConceptScore W3026970913C170493617 @default.
• W3026970913 hasConceptScore W3026970913C2776029756 @default.
• W3026970913 hasConceptScore W3026970913C2776814716 @default.
• W3026970913 hasConceptScore W3026970913C2780269707 @default.
• W3026970913 hasConceptScore W3026970913C2780778865 @default.
• W3026970913 hasConceptScore W3026970913C2780820201 @default.
• W3026970913 hasConceptScore W3026970913C2781063702 @default.
• W3026970913 hasConceptScore W3026970913C2781302539 @default.
• W3026970913 hasConceptScore W3026970913C42219234 @default.
• W3026970913 hasConceptScore W3026970913C71924100 @default.
• W3026970913 hasIssue "2" @default.
• W3026970913 hasLocation W30269709131 @default.
• W3026970913 hasLocation W30269709132 @default.
• W3026970913 hasLocation W30269709133 @default.
• W3026970913 hasOpenAccess W3026970913 @default.
• W3026970913 hasPrimaryLocation W30269709131 @default.
• W3026970913 hasRelatedWork W2235935726 @default.
• W3026970913 hasRelatedWork W2371048632 @default.
• W3026970913 hasRelatedWork W2624736328 @default.
• W3026970913 hasRelatedWork W2898002627 @default.
• W3026970913 hasRelatedWork W3029045828 @default.
• W3026970913 hasRelatedWork W3032257214 @default.
• W3026970913 hasRelatedWork W3164788400 @default.
• W3026970913 hasRelatedWork W4205159005 @default.
• W3026970913 hasRelatedWork W4323267816 @default.
• W3026970913 hasRelatedWork W2945766552 @default.
• W3026970913 hasVolume "20" @default.
• W3026970913 isParatext "false" @default.
• W3026970913 isRetracted "false" @default.
• W3026970913 magId "3026970913" @default.
• W3026970913 workType "article" @default.